Why we celebrate International Clinical Trials Day
The clinical trial industry is booming with innovation. Researchers, scientists and pharmaceutical sponsors are pushing the limits for what’s possible in drug development and they’re working day and night to bring drugs to market faster; ultimately providing a cure or treatment to patients in need.
It’s hard to believe the industry is less than 300 years old. It’s even harder to believe the industry “began” on a boat—the Salisbury—in 1747 when Dr. James Lind, a British naval surgeon, brought 12 patients suffering from scurvy on board to determine if citrus fruits alleviated their symptoms. This is the first recorded clinical trial and as it turns out, Lind was right.
Based on all of the laws and regulations in the pharmaceutical and clinical trial industries, one would assume these standards would have been in place since early in the development of the industry. Think again! It wasn’t until 1947— 200 years after Lind’s scurvy trial—that the Nuremberg Code was formulated, providing the first international guidance on the ethics of medical research involving subjects.
As clinical trial guidelines developed, the standards for medicinal treatments grew in parallel. According to medical historian Harry Marks, statistically-based clinical trials became a critically important part of evidence-based medicine in the United States after WWII.
Fast forward 70 years, there are now more than 191,000 clinical trials taking place in 190 countries around the world; this represents enormous growth across the industry that’s working to improve and save patient’s lives.
Various elements play a critical role in conducting a successful clinical trial—we believe technology can make a significant impact here today and in the future. The many moving parts in a clinical trial make it highly susceptible to needless errors, both technical and human, which create costly inefficiencies in the system, slow the decision-making process, and can have a significant negative impact on the trial.
Did you know that more than half of all image-related clinical trial query stoppages result from preventable human errors? These errors cause an average delay of up to seven weeks.
AG Mednet developed the industry’s first automated, quality control platform for that detects errors in clinical trial data submissions at the source, before they leave the investigator site and cause delays. What used to be done manually, is now checked automatically with AG Mednet’s software, cutting avoidable query delays by 75% for pharmaceutical sponsors.
Last year, we processed more than 48 million images representing 114,000 exams. This growth is evidence that more and more trials are moving away from shipping CDs via courier or primitive ‘eTransfer’ solutions to using our technology for not only more exams, but larger exams. This upswing in adoption ultimately means increased efficiencies and improved quality, proving that the industry is moving toward zero-delay clinical trials.
International Clinical Trials Day is a time to celebrate all the hard work and strides doctors, patients and companies have made in the last year. It’s also a time to think about the future of clinical trials and where the industry is going next. What do you want to celebrate a year from now? Share with us on Twitter @AGMednet using #ClinicalTrialsDay.